Spanish study tracks rare muscle disease to speed future treatments
NCT ID NCT07488806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 people in Spain with nemaline myopathy, a rare muscle disease, to see how their symptoms change over time. Researchers will use ultrasound, movement tests, and breathing checks to map the disease's natural course. The goal is to build a detailed patient database that can help design and recruit for future treatment trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTA1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could depression before surgery raise delirium risk in seniors?
- UK study tracks rare muscle disease to pave way for future treatments
- War's hidden toll: new study to examine reproductive decisions and mental health in ukrainian women
- Heart surgery in infants: new study reveals hidden Long-Term risks
- New handheld scanner could replace MRI for muscle disease monitoring
- Shocking muscles to move: new exercise hope for nerve disease patients